Table 1.
Figures in parentheses are percentages.*1P < 0.05; *2P < 0.01; *3P < 0.005; *4P < 0.001 when compared with the respective remaining group; *5P < 0.05 when compared with each other; *6P < 0.025 when compared with each other; *7P < 0.025 when compared with each other; *8P < 0.025 when compared with each other; *9P < 0.005 when compared with each other; *10P < 0.005 when compared with each other; *11P < 0.001 when compared with each other (all comparisons by χ2 test with Yates' correction where appropriate).
† For details, see text.
‡ For organ involvement definitions, see text.
§ Total numbers of patients on whom this category of clinical information was available.
¶ Some sera had multiple antibody specificities.
** Determined by immunoblotting and/or immunofluorescence assays.
*** Th RNP, U3 RNP, Ku, Pm-Scl and/or PL-7.
RNAP, RNA polymerase; topo I, topoisomerase I; CENPs, centromere proteins.